<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00779792</url>
  </required_header>
  <id_info>
    <org_study_id>2008-001678-34</org_study_id>
    <nct_id>NCT00779792</nct_id>
  </id_info>
  <brief_title>Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation</brief_title>
  <acronym>WA+TR_1</acronym>
  <official_title>Comparison of Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Experimentally Induced Skin Irritation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>LEO Pharma</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy of glycerol ointment, triamcinolone
      acetonide ointment, clobetasol ointment and tacrolimus ointment on irritated skin in a
      cumulative skin irritation test model using healthy volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Irritant contact dermatitis (ICD) is a frequent cause of hand eczema and occupational skin
      disease. One way to study ICD is to expose healthy volunteer skin to chemicals and evaluate
      the skin response. Because different chemicals act differently on the skin, the use of
      different skin irritants may provide more information than relying on one irritant only. In
      this study the two commonly used irritants sodium lauryl sulphate and nonanoic acid are
      exposed to the skin in a cumulative wash test. Treatment of ICD has classically involved
      topical steroids and/or emollients. However, the outcome is variable with some patients being
      very refractory to this regimen. This study was designed to investigate the relative efficacy
      of the steroids triamcinolone acetonide and clobetasol, the topical immune modulator
      tacrolimus, a 20% Glycerol ointment compared with an inert ointment vehicle on experimentally
      induced irritated skin.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">November 2008</completion_date>
  <primary_completion_date type="Anticipated">November 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>level of skin irritation as determined by visual reading, skin redness (color measurement), skin barrier integrity (transepidermal water loss measurement) and skin hydration (capacitance measurement)</measure>
    <time_frame>End of treatment and summary measure (Area under the curve) of consecutive measurements at visit every other day for 10 days</time_frame>
  </primary_outcome>
  <enrollment type="Actual">36</enrollment>
  <condition>Dermatitis, Contact</condition>
  <condition>Dermatitis, Occupational</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clobetasol</intervention_name>
    <description>0.5 mg Clobetasol propionate (0.5 mg/g) ointment applied twice daily for 10 consecutive days</description>
    <other_name>Dermovate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>triamcinolone acetonide</intervention_name>
    <description>0.5 mg ointment twice daily for 10 consecutive days</description>
    <other_name>Kenalog</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tacrolimus</intervention_name>
    <description>0.5 mg tacrolimus ointment(0.1%) twice daily for 10 consecutive days</description>
    <other_name>Protopic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>glycerol</intervention_name>
    <description>0.5 mg glycerol ointment (20%) twice daily for 10 consecutive days</description>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vehicle ointment (paraffin oil/soft white paraffin)</intervention_name>
    <description>0.5 mg vehicle ointment twice daily for 10 consecutive days</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  caucasian

          -  normal skin on both volar forearms

          -  oral and written informed consent

        Exclusion Criteria:

          -  pregnant, lactating women

          -  no safe anticonceptive method used

          -  intake of systemic immunosuppressants (e.g. prednisolone)

          -  endocrine, immune, or liver disorders

          -  known allergy towards drugs applied to the skin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anders Clemmensen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dermatology, Odense University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Dermatology, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE. Comparison of the effect of glycerol and triamcinolone acetonide on cumulative skin irritation in a randomized trial. J Am Acad Dermatol. 2007 Feb;56(2):228-35. Epub 2006 Dec 6.</citation>
    <PMID>17156893</PMID>
  </reference>
  <reference>
    <citation>Schliemann S, Kelterer D, Bauer A, John SM, Skudlik C, Schindera I, Wehrmann W, Elsner P. Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Contact Dermatitis. 2008 May;58(5):299-306. doi: 10.1111/j.1600-0536.2007.01314.x.</citation>
    <PMID>18416762</PMID>
  </reference>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2008</study_first_submitted>
  <study_first_submitted_qc>October 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2008</study_first_posted>
  <last_update_submitted>October 23, 2008</last_update_submitted>
  <last_update_submitted_qc>October 23, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 24, 2008</last_update_posted>
  <responsible_party>
    <name_title>Anders Clemmensen, MD</name_title>
    <organization>Odense University Hospital</organization>
  </responsible_party>
  <keyword>Irritant contact dermatitis</keyword>
  <keyword>experimental contact dermatitis</keyword>
  <keyword>treatment</keyword>
  <keyword>efficacy</keyword>
  <keyword>topical steroids</keyword>
  <keyword>topical immune modulators</keyword>
  <keyword>glycerol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Contact</mesh_term>
    <mesh_term>Dermatitis, Occupational</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
    <mesh_term>Immunologic Factors</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Clobetasol</mesh_term>
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

